StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol-Myers Squibb Co. (BMY) PT Raised to $55 at Leerink Partners
November 4, 2024 6:20 AM
Leerink Partners analyst David Risinger raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $55.00 (from $53.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Bristol-Myers Squibb Co. (BMY) PT Raised to $57 at BMO Capital
November 1, 2024 8:05 AM
Bristol-Myers Squibb (BMY) Presents New Long-term Data from the EMERGENT Program Evaluating COBENFY
October 31, 2024 4:16 PM
Bristol Myers Squibb Presents New Long-term Data from the EMERGENT Program Evaluating COBENFY™ (xanomeline and trospium chloride) in Adults with Schizophrenia at Psych Congress 2024
October 31, 2024 4:16 PM
Form 10-Q BRISTOL MYERS SQUIBB CO For: Sep 30
October 31, 2024 11:45 AM
Form 8-K BRISTOL MYERS SQUIBB CO For: Oct 31
October 31, 2024 7:53 AM
Bristol-Myers hikes annual earnings guidance as Q3 exceeds expectations; shares up
October 31, 2024 7:36 AM
Bristol Myers earnings beat expectations, driven by sales of older drugs
October 31, 2024 7:19 AM
Bristol-Myers Squibb (BMY) Tops Q3 EPS by 30c, provides guidance
October 31, 2024 7:01 AM
Bristol Myers Squibb Reports Third Quarter Financial Results for 2024
October 31, 2024 6:59 AM
